1. Home
  2. IOVA vs REAX Comparison

IOVA vs REAX Comparison

Compare IOVA & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.22

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$3.89

Market Cap

790.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
REAX
Founded
2007
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
968.6M
790.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IOVA
REAX
Price
$2.22
$3.89
Analyst Decision
Buy
Strong Buy
Analyst Count
12
3
Target Price
$10.36
$6.33
AVG Volume (30 Days)
16.6M
1.3M
Earning Date
11-06-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,425,000.00
$1,813,907,000.00
Revenue This Year
$60.94
$56.57
Revenue Next Year
$60.85
$21.77
P/E Ratio
N/A
N/A
Revenue Growth
175.62
65.60
52 Week Low
$1.64
$3.42
52 Week High
$9.30
$5.65

Technical Indicators

Market Signals
Indicator
IOVA
REAX
Relative Strength Index (RSI) 47.43 52.02
Support Level $2.13 $3.73
Resistance Level $2.55 $4.01
Average True Range (ATR) 0.16 0.15
MACD -0.03 0.03
Stochastic Oscillator 25.57 76.61

Price Performance

Historical Comparison
IOVA
REAX

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: